Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | STAT3 | P40763 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 2/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Choline SCHEMBL6362242 | 0.88 | ALDH1A1 (0.43) | ALDH1A1KMT2AGAALMNASTAT3 | |
| SCHEMBL4881543 | 0.87 | ALDH1A1 (0.55) | ALDH1A1KMT2AGAALMNASTAT3 | |
| SCHEMBL8842257 | 0.86 | ALDH1A1 (0.50) | ALDH1A1KMT2AGAALMNASTAT3 | |
| SCHEMBL5685915 | 0.84 | ALDH1A1 (0.56) | ALDH1A1KMT2AGAASTAT3F2 | |
| SCHEMBL493092 | 0.84 | ALDH1A1 (0.51) | ALDH1A1KMT2AGAASTAT3F2 | |
| SCHEMBL27297266 | 0.84 | ALDH1A1 (0.51) | ALDH1A1KMT2AGAALMNASTAT3 | |
| SCHEMBL4201426 | 0.83 | ALDH1A1 (0.50) | ALDH1A1KMT2AGAASTAT3F2 | |
| SCHEMBL6543497 | 0.83 | HSD11B1 (0.50) | ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL28069479 | 0.83 | ALDH1A1 (0.47) | ALDH1A1KMT2AGAALMNASTAT3 | |
| SCHEMBL27659885 | 0.83 | ALDH1A1 (0.47) | ALDH1A1KMT2AGAALMNASTAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111655680-B | Hormone receptor modulators for the treatment of metabolic mutations and fibrotic conditions and disorders | 阿德利克斯股份有限公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-113453724-A | Sulfonylmaleimide-based linkers and corresponding conjugates | 皮埃尔法布雷医药公司 | 2021-09-28 | — | — | CN | disclosed |
| CN-104945404-B | A kind of preparation method of N- propenecarbonyls piperidine derivative | 广东东阳光药业有限公司 | 2018-09-14 | — | — | CN | disclosed |
| CN-106132972-B | Phosphoramidate for treating HCV infection | 银杏树药业(苏州)有限公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-104945404-A | Method for preparing N-propylene carbonyl piperidine derivative | GUANGDONG HEC PHARMACEUTICAL | 2015-09-30 | — | — | CN | disclosed |
| CN-102863510-B | N (2)-L-alanyl-L-glutamine synthetic method | SHANDONG JINCHENG PHARMACEUTICAL & CHEMICAL CO LTD | 2014-06-04 | — | — | CN | disclosed |
| US-8724296-B2 | Solid electrolytic capacitor and fabrication method thereof | SANYO ELECTRIC CO., LTD. (JP) | 2014-05-13 | — | — | US | disclosed |
| US-8425805-B2 | Conductive polymer film, electronic device, and methods of producing the film and the device | SANYO ELECTRIC CO., LTD. (JP) | 2013-04-23 | — | — | US | disclosed |
| CN-102863510-A | N (2)-L-alanyl-L-glutamine synthetic method | SHANDONG JINCHENG PHARMACEUTICAL & CHEMICAL CO LTD | 2013-01-09 | — | — | CN | disclosed |
| US-20120049136-A1 | CONDUCTIVE POLYMER FILM, ELECTRIC DEVICES AND METHODS FOR MANUFACTURING THE CONDUCTIVE POLYMER FILM | SANYO ELECTRIC CO., LTD. (JP) | 2012-03-01 | — | — | US | disclosed |
| WO-2004064762-A9 | NOVEL COCRYSTALLIZATION | S S C I INC (US) | 2006-07-27 | — | — | WO | disclosed |
| EP-1596869-A2 | NOVEL COCRYSTALLIZATION | S.S.C.I., Inc (US) | 2005-11-23 | — | — | EP | disclosed |
| WO-2005089375-A2 | SCREENING FOR SOLID FORMS BY ULTRASOUND CRYSTALLIZATION AND COCRYSTALLIZATION USING ULTRASOUND | S.S.C.I., INC. (US) | 2005-09-29 | — | — | WO | disclosed |
| WO-2004064762-A2 | NOVEL COCRYSTALLIZATION | S.S.C.I. INC. (US) | 2004-08-05 | — | — | WO | disclosed |
| US-20040106808-A1 | Processes for preparing calanolide a and intermediates thereof | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 2004-06-03 | — | — | US | disclosed |
| EP-1352907-A1 | PROCESSES FOR PREPARING CALANOLIDE A AND INTERMEDIATES THEREOF | KURARAY CO., LTD. (JP) | 2003-10-15 | — | — | EP | disclosed |
| EP-0916654-A1 | SULFONIC ESTER DERIVATIVES, PROCESS FOR PREPARING THE SAME, AND USE THEREOF | KANEKA CORPORATION (JP) | 1999-05-19 | — | — | EP | disclosed |
| US-4943514-A | POLYMERIC MORDANT FROM QUATERNIZED VINYLIMIDAZOLE | EASTMAN KODAK COMPANY (US) | 1990-07-24 | — | — | US | disclosed |
| US-4942103-A | POLYVINYL ALCOHOL BINDERS, RADIATION SENSITIVE DICHROMATES, A POLYMERIC MORDANT OF QUATERNIZED N-VINYLIMIDAZOLES | EASTMAN KODAK COMPANY (US) | 1990-07-17 | — | — | US | disclosed |
| CN-86103619-A | The preparation method of the bicyclic pyrazolidinones that 7-replaces | — | 1986-10-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106808-A1 | Processes for preparing calanolide a and intermediates thereof | CALR, CYP51A1, CYP4A11 | ALDH1A1 1043/4885KMT2A 3255/4885GAA 348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.